165 related articles for article (PubMed ID: 37984720)
1. Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculator.
McEvoy AM; Hippe DS; Lachance K; Park S; Cahill K; Redman M; Gooley T; Kattan MW; Nghiem P
J Am Acad Dermatol; 2024 Mar; 90(3):569-576. PubMed ID: 37984720
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis.
McEvoy AM; Lachance K; Hippe DS; Cahill K; Moshiri Y; Lewis CW; Singh N; Park SY; Thuesmunn Z; Cook MM; Alexander NA; Zawacki L; Thomas H; Paulson KG; Nghiem P
JAMA Dermatol; 2022 Apr; 158(4):382-389. PubMed ID: 35195657
[TBL] [Abstract][Full Text] [Related]
3. A web-based predictive model for overall survival of patients with cutaneous Merkel cell carcinoma: A population-based study.
Xu W; Le Y; Zhang J
Front Endocrinol (Lausanne); 2022; 13():1038181. PubMed ID: 36506062
[TBL] [Abstract][Full Text] [Related]
4. Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma.
Yin X; She H; Martin Kasyanju Carrero L; Ma W; Zhou B
Ann Transl Med; 2021 Feb; 9(4):286. PubMed ID: 33708913
[TBL] [Abstract][Full Text] [Related]
5. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
6. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Vlahova L; Doerflinger Y; Houben R; Becker JC; Schrama D; Weiss C; Goebeler M; Helmbold P; Goerdt S; Peitsch WK
Br J Dermatol; 2012 May; 166(5):1043-52. PubMed ID: 22283194
[TBL] [Abstract][Full Text] [Related]
7. Tumor primary site as a prognostic factor for Merkel cell carcinoma disease-specific death.
Cullison CR; Zheng DX; Levoska MA; Scott JF; Bordeaux JS
J Am Acad Dermatol; 2021 Nov; 85(5):1259-1266. PubMed ID: 34197874
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
Wu CF; Lv JW; Lin L; Mao YP; Deng B; Zheng WH; Wen DW; Chen Y; Kou J; Chen FP; Yang XL; Zheng ZQ; Li ZX; Xu SS; Ma J; Sun Y
Cancer Commun (Lond); 2021 Jan; 41(1):37-50. PubMed ID: 33270990
[TBL] [Abstract][Full Text] [Related]
9. Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression.
Bryant MK; Ward C; Gaber CE; Strassle PD; Ollila DW; Laks S
J Surg Oncol; 2020 Sep; 122(4):653-659. PubMed ID: 32562583
[TBL] [Abstract][Full Text] [Related]
10. Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma.
Tseng YD; Nguyen MH; Baker K; Cook M; Redman M; Lachance K; Bhatia S; Liao JJ; Apisarnthanarax S; Nghiem PT; Parvathaneni U
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):330-339. PubMed ID: 30191867
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
12. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.
Bhatia S; Storer BE; Iyer JG; Moshiri A; Parvathaneni U; Byrd D; Sober AJ; Sondak VK; Gershenwald JE; Nghiem P
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27245173
[TBL] [Abstract][Full Text] [Related]
14. Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.
Liu KX; Milligan MG; Schoenfeld JD; Tishler RB; Ng AK; Devlin PM; Fite E; Rabinowits G; Hanna GJ; Silk AW; Yoon CH; Thakuria M; Margalit DN
Radiother Oncol; 2022 Aug; 173():32-40. PubMed ID: 35595174
[TBL] [Abstract][Full Text] [Related]
15. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic nomograms and a web-based survival rate calculator for sarcomatoid renal cell carcinoma in pre- and post-treatment patients.
Yang T; Wu Y; Zuo Y; Fu S; Xu Z; Yu N
Transl Androl Urol; 2021 Feb; 10(2):754-764. PubMed ID: 33718077
[TBL] [Abstract][Full Text] [Related]
17. Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma.
Lin Z; Lin H; Lin C
Int J Clin Oncol; 2020 Jul; 25(7):1260-1269. PubMed ID: 32266595
[TBL] [Abstract][Full Text] [Related]
18. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
[TBL] [Abstract][Full Text] [Related]
19. Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer.
Weiser MR; Hsu M; Bauer PS; Chapman WC; González IA; Chatterjee D; Lingam D; Mutch MG; Keshinro A; Shia J; Vakiani E; Konishi T; Shimada Y; Stadler Z; Segal NH; Cercek A; Saltz L; Yaeger R; Varghese A; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash G; Paty P; Garcia-Aguilar J; Gonen M
J Clin Oncol; 2021 Mar; 39(8):911-919. PubMed ID: 33439688
[TBL] [Abstract][Full Text] [Related]
20. Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
Chou WC; Chang KP; Lu CH; Chen MF; Cheng YF; Yeh KY; Wang CH; Lin YC; Yeh TS
Head Neck; 2017 May; 39(5):860-867. PubMed ID: 28152230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
